DRMAW
Dermata Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−50.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-96.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 6, 2026 | PROEHL GERALD T · director, 10 percent owner, officer: President, CEO and Chairman | A-Award | 37,500 | $2.18 |
| Jan 6, 2026 | WIERENGA WENDELL · director | A-Award | 2,500 | $2.18 |
| Jan 6, 2026 | HALE DAVID F · director | A-Award | 2,500 | $2.18 |
| Jan 6, 2026 | Bedoya-Toro Munera Maria E · officer: SVP, Regulatory Affairs | A-Award | 9,000 | $2.18 |
| Jan 6, 2026 | Scott Kathleen D. · director | A-Award | 2,500 | $2.18 |
| Jan 6, 2026 | Nardo Christopher J. · officer: Senior VP, CDO | A-Award | 18,000 | $2.18 |
| Jan 6, 2026 | Sandler Andrew Seth · director | A-Award | 2,500 | $2.18 |
| Jan 6, 2026 | Van Hoose Kyri K. · officer: SVP, CFO | A-Award | 18,000 | $2.18 |
| Jan 6, 2026 | Mento Steven J · director | A-Award | 2,500 | $2.18 |
| Jan 6, 2026 | Bradrick Brittany · director | A-Award | 2,500 | $2.18 |
| Jan 6, 2026 | FISHER MARY · director | A-Award | 2,500 | $2.18 |
| Dec 29, 2025 | Van Hoose Kyri K. · officer: SVP, CFO | A-Award | 122,549 | $0.00 |
| Dec 29, 2025 | Van Hoose Kyri K. · officer: SVP, CFO | A-Award | 7,874 | $2.04 |
| Dec 29, 2025 | PROEHL GERALD T · director, 10 percent owner, officer: PRESIDENT, CHAIRMAN, CEO | A-Award | 490,196 | $2.04 |
| Dec 29, 2025 | PROEHL GERALD T · director, 10 percent owner, officer: PRESIDENT, CHAIRMAN, CEO | A-Award | 122,549 | $0.00 |
| Dec 29, 2025 | PROEHL GERALD T · director, 10 percent owner, officer: PRESIDENT, CHAIRMAN, CEO | A-Award | 78,740 | $2.04 |
| Jan 23, 2025 | FISHER MARY · director | A-Award | 196,851 | $0.00 |
| Jan 23, 2025 | Van Hoose Kyri K. · officer: SVP, CFO | A-Award | 78,741 | $0.00 |
| Jan 23, 2025 | PROEHL GERALD T · director, 10 percent owner, officer: President, CEO and Chairman | A-Award | 787,402 | $0.00 |
| Jan 23, 2025 | HALE DAVID F · director | A-Award | 78,741 | $0.00 |
| Jan 14, 2025 | Sandler Andrew Seth · director | A-Award | 5,000 | $1.38 |
| Jan 14, 2025 | Nardo Christopher J. · officer: Senior VP, CDO | A-Award | 20,000 | $1.38 |
| Jan 14, 2025 | Bradrick Brittany · director | A-Award | 5,000 | $1.38 |
| Jan 14, 2025 | Bedoya-Toro Munera Maria E · officer: SVP, Regulatory Affairs | A-Award | 8,000 | $1.38 |
| Jan 14, 2025 | HALE DAVID F · director | A-Award | 5,000 | $1.38 |
| Jan 14, 2025 | WIERENGA WENDELL · director | A-Award | 5,000 | $1.38 |
| Jan 14, 2025 | FISHER MARY · director | A-Award | 5,000 | $1.38 |
| Jan 14, 2025 | Van Hoose Kyri K. · officer: SVP, CFO | A-Award | 20,000 | $1.38 |
| Jan 14, 2025 | PROEHL GERALD T · director, officer: President, CEO and Chairman | A-Award | 45,000 | $1.38 |
| Jan 14, 2025 | Mento Steven J · director | A-Award | 5,000 | $1.38 |
Institutional positioning
13F filings over the trailing two quarters
New 1Increased 0Reduced 0Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | Unchanged | 12,000 | May 15, 2026 |
| UBS GROUP AG | New Position | 1,304 | May 5, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 6, 2026